Should we overcome the resistance to bioelectrical impedance in heart failure?

References

• Jackson G, Gibbs CR, Davies MK, et al. ABC of heart failure. Pathophysiology. BMJ. 2000 Jan 15;320(7228):167–170.
   PubMedGoogle Scholar
• Castillo-Martinez L, Colin-Ramirez E, Orea-Tejeda A, et al. Bioelectrical impedance and strength measurements in patients with heart failure: comparison with functional class. Nutrition. 2007 May;23(5):412–418.
   PubMed Web of Science ®Google Scholar
• Kyle UG, Bosaeus I, De Lorenzo AD, et al. Bioelectrical impedance analysis-part II: utilization in clinical practice. Clin Nutr. 2004 Dec;23(6):1430–1453.
   PubMed Web of Science ®Google Scholar
• Lukaski HC. Requirements for clinical use of bioelectrical impedance analysis (BIA). Ann N Y Acad Sci. 1999 Apr;20(873):72–76.
   Google Scholar
• Kyle UG, Bosaeus I, De Lorenzo AD, et al. Bioelectrical impedance analysis–part I: review of principles and methods. Clin Nutr. 2004 Oct;23(5):1226–1243.
   PubMed Web of Science ®Google Scholar
• Piccoli A, Codognotto M, Cianci V, et al. Differentiation of cardiac and noncardiac dyspnea using bioelectrical impedance vector analysis (BIVA). J Card Fail. 2012 Mar;18(3):226–232.
   PubMed Web of Science ®Google Scholar
• Zile MR, Bennett TD, St John Sutton M, et al. Transition from chronic compensated to acute decompensated heart failure: pathophysiological insights obtained from continuous monitoring of intracardiac pressures. Circulation. 2008 Sep 30;118(14):1433–1441.
   PubMed Web of Science ®Google Scholar
• Mentz RJ, Mi X, Sharma PP, et al. Relation of dyspnea severity on admission for acute heart failure with outcomes and costs. Am J Cardiol. 2015 Jan 1;115(1):75–81.
   PubMed Web of Science ®Google Scholar
• Gheorghiade M, Follath F, Ponikowski P, et al. Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine. Eur J Heart Fail. 2010 May;12(5):423–433.
   PubMed Web of Science ®Google Scholar
• Gheorghiade M, Filippatos G, De Luca L, et al. Congestion in acute heart failure syndromes: an essential target of evaluation and treatment. Am J Med. 2006 Dec;119(12 Suppl 1):S3–S10.
   PubMed Web of Science ®Google Scholar
• Chaudhry SI, Wang Y, Concato J, et al. Patterns of weight change preceding hospitalization for heart failure. Circulation. 2007 Oct 2;116(14):1549–1554.
   PubMed Web of Science ®Google Scholar
• Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016 Jul 14;37(27):2129–2200.
   PubMed Web of Science ®Google Scholar
• Lewin J, Ledwidge M, O’Loughlin C, et al. Clinical deterioration in established heart failure: what is the value of BNP and weight gain in aiding diagnosis? Eur J Heart Fail. 2005 Oct;7(6):953–957.
   PubMed Web of Science ®Google Scholar
• Kociol RD, McNulty SE, Hernandez AF, et al. Markers of decongestion, dyspnea relief, and clinical outcomes among patients hospitalized with acute heart failure. Circ Heart Fail. 2013 Mar;6(2):240–245.
   PubMed Web of Science ®Google Scholar
• Yu C-M, Wang L, Chau E, et al. Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization. Circulation. 2005 Aug 9;112(6):841–848.
   PubMed Web of Science ®Google Scholar
• Vanderheyden M, Houben R, Verstreken S, et al. Continuous monitoring of intrathoracic impedance and right ventricular pressures in patients with heart failure. Circ Heart Fail. 2010 May;3(3):370–377.
   PubMed Web of Science ®Google Scholar
• Tomasi L, Zanotto G, Zanolla L, et al. Physiopathologic correlates of intrathoracic impedance in chronic heart failure patients. Pacing Clin Electrophysiol. 2011 Apr;34(4):407–413.
   PubMed Web of Science ®Google Scholar
• Vollmann D, Nagele H, Schauerte P, et al. Clinical utility of intrathoracic impedance monitoring to alert patients with an implanted device of deteriorating chronic heart failure. Eur Heart J. 2007 Aug;28(15):1835–1840.
   PubMed Web of Science ®Google Scholar
• Ypenburg C, Bax JJ, van der Wall EE, et al. Intrathoracic impedance monitoring to predict decompensated heart failure. Am J Cardiol. 2007 Feb 15;99(4):554–557.
   PubMed Web of Science ®Google Scholar
• Catanzariti D, Lunati M, Landolina M, et al. Monitoring intrathoracic impedance with an implantable defibrillator reduces hospitalizations in patients with heart failure. Pacing Clin Electrophysiol. 2009 Mar;32(3):363–370.
   PubMed Web of Science ®Google Scholar
• Gudmundsson K, Lynga P, Rosenqvist M, et al. Monitoring of daily body weight and intrathoracic impedance in heart failure patients with a high risk of volume overload decompensation. Clin Cardiol. 2016 Aug;39(8):446–452.
   PubMed Web of Science ®Google Scholar
• Conraads VM, Tavazzi L, Santini M, et al. Sensitivity and positive predictive value of implantable intrathoracic impedance monitoring as a predictor of heart failure hospitalizations: the SENSE-HF trial. Eur Heart J. 2011 Sep;32(18):2266–2273.
   PubMed Web of Science ®Google Scholar
• van Veldhuisen DJ, Braunschweig F, Conraads V, et al. Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure. Circulation. 2011 Oct 18;124(16):1719–1726.
   PubMed Web of Science ®Google Scholar
• Bohm M, Drexler H, Oswald H, et al. Fluid status telemedicine alerts for heart failure: a randomized controlled trial. Eur Heart J. 2016 Nov 1;37(41):3154–3163.
   PubMed Web of Science ®Google Scholar
• Dickinson MG, Allen LA, Albert NA, et al. Remote monitoring of patients with heart failure: a white paper from the heart failure society of America scientific statements committee. J Card Fail. 2018 Oct;24(10):682–694.
   PubMed Web of Science ®Google Scholar
• Whellan DJ, Ousdigian KT, Al-Khatib SM, et al. Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study. J Am Coll Cardiol. 2010 Apr 27;55(17):1803–1810.
   PubMed Web of Science ®Google Scholar
• Abraham WT, Compton S, Haas G, et al. Intrathoracic impedance vs daily weight monitoring for predicting worsening heart failure events: results of the Fluid Accumulation Status Trial (FAST). Congest Heart Fail. 2011 Mar-Apr;17(2):51–55.
   PubMedGoogle Scholar
• Tang WH, Warman EN, Johnson JW, et al. Threshold crossing of device-based intrathoracic impedance trends identifies relatively increased mortality risk. Eur Heart J. 2012 Sep;33(17):2189–2196.
   PubMed Web of Science ®Google Scholar
• Boehmer JP, Hariharan R, Devecchi FG, et al. A multisensor algorithm predicts heart failure events in patients with implanted devices: results from the multisense study. JACC Heart Fail. 2017 Mar;5(3):216–225.
   PubMed Web of Science ®Google Scholar
• Shochat MK, Shotan A, Blondheim DS, et al. Non-invasive lung IMPEDANCE-guided preemptive treatment in chronic heart failure patients: a randomized controlled trial (IMPEDANCE-HF trial). J Card Fail. 2016 Sep;22(9):713–722.
   PubMed Web of Science ®Google Scholar
• Shochat MK, Fudim M, Shotan A, et al. Prediction of readmissions and mortality in patients with heart failure: lessons from the IMPEDANCE-HF extended trial. ESC Heart Fail. 2018 Oct;5(5):788–799.
   PubMed Web of Science ®Google Scholar
• Shochat M, Charach G, Meyler S, et al. Prediction of cardiogenic pulmonary edema onset by monitoring right lung impedance. Intensive Care Med. 2006 Aug;32(8):1214–1221.
   PubMed Web of Science ®Google Scholar
• Ambrosy AP, Pang PS, Khan S, et al. Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial. Eur Heart J. 2013 Mar;34(11):835–843.
   PubMed Web of Science ®Google Scholar
• Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013 Oct 15;62(16):e147–239.
   PubMed Web of Science ®Google Scholar
• Shochat M, Shotan A, Blondheim DS, et al. Usefulness of lung impedance-guided pre-emptive therapy to prevent pulmonary edema during ST-elevation myocardial infarction and to improve long-term outcomes. Am J Cardiol. 2012 Jul 15;110(2):190–196.
   PubMed Web of Science ®Google Scholar
• Abraham WT, Adamson PB, Bourge RC, et al. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet. 2011 Feb 19;377(9766):658–666.
   PubMed Web of Science ®Google Scholar
• Abraham WT, Stevenson LW, Bourge RC, et al. Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial. Lancet. 2016 Jan 30;387(10017):453–461.
   PubMed Web of Science ®Google Scholar
• United States National Library of Medicine. 2020 March 27. Available from: https://clinicaltrials.gov/ct2/show/NCT02661841?term=%22lung+impedance%22&rank=3
   Google Scholar
• Franssen FM, Rutten EP, Groenen MT, et al. New reference values for body composition by bioelectrical impedance analysis in the general population: results from the UK Biobank. J Am Med Dir Assoc. 2014 Jun;15(6):448e1–6.
   Web of Science ®Google Scholar
• Parrinello G, Paterna S, Di Pasquale P, et al. The usefulness of bioelectrical impedance analysis in differentiating dyspnea due to decompensated heart failure. J Card Fail. 2008 Oct;14(8):676–686.
   PubMed Web of Science ®Google Scholar
• Lyons KJ, Bischoff MK, Fonarow GC, et al. Noninvasive bioelectrical impedance for predicting clinical outcomes in outpatients with heart failure. Crit Pathw Cardiol. 2017 Mar;16(1):32–36.
   PubMedGoogle Scholar
• Lukaski HC, Vega Diaz N, Talluri A, et al. Classification of hydration in clinical conditions: indirect and direct approaches using bioimpedance. Nutrients. 2019 Apr 10;11(4):1-22.
   Web of Science ®Google Scholar
• Ronco C, Kaushik M, Valle R, et al. Diagnosis and management of fluid overload in heart failure and cardio-renal syndrome: the “5B” approach. Semin Nephrol. 2012 Jan;32(1):129–141.
   PubMed Web of Science ®Google Scholar
• Alves FD, Souza GC, Aliti GB, et al. Dynamic changes in bioelectrical impedance vector analysis and phase angle in acute decompensated heart failure. Nutrition. 2015 Jan;31(1):84–89.
   PubMed Web of Science ®Google Scholar
• Di Somma S, Lalle I, Magrini L, et al. Additive diagnostic and prognostic value of bioelectrical impedance vector analysis (BIVA) to brain natriuretic peptide ‘grey-zone’ in patients with acute heart failure in the emergency department. Eur Heart J Acute Cardiovasc Care. 2014 Jun;3(2):167–175.
   PubMedGoogle Scholar
• Genot N, Mewton N, Bresson D, et al. Bioelectrical impedance analysis for heart failure diagnosis in the ED. Am J Emerg Med. 2015 Aug;33(8):1025–1029.
   PubMed Web of Science ®Google Scholar
• Massari F, Iacoviello M, Scicchitano P, et al. Accuracy of bioimpedance vector analysis and brain natriuretic peptide in detection of peripheral edema in acute and chronic heart failure. Heart Lung. 2016 Jul-Aug;45(4):319–326.
   PubMed Web of Science ®Google Scholar
• Massari F, Scicchitano P, Ciccone MM, et al. Bioimpedance vector analysis predicts hospital length of stay in acute heart failure. Nutrition. 2019 May;61:56–60.
   PubMed Web of Science ®Google Scholar
• Nunez J, Mascarell B, Stubbe H, et al. Bioelectrical impedance vector analysis and clinical outcomes in patients with acute heart failure. J Cardiovasc Med (Hagerstown). 2016 Apr;17(4):283–290.
   PubMed Web of Science ®Google Scholar
• Colin-Ramirez E, Castillo-Martinez L, Orea-Tejeda A, et al. Bioelectrical impedance phase angle as a prognostic marker in chronic heart failure. Nutrition. 2012 Sep;28(9):901–905.
   PubMed Web of Science ®Google Scholar
• Alves FD, Souza GC, Clausell N, et al. Prognostic role of phase angle in hospitalized patients with acute decompensated heart failure. Clin Nutr. 2016 Dec;35(6):1530–1534.
   PubMed Web of Science ®Google Scholar
• Santarelli S, Russo V, Lalle I, et al. Prognostic value of decreased peripheral congestion detected by bioelectrical impedance vector analysis (BIVA) in patients hospitalized for acute heart failure: BIVA prognostic value in acute heart failure. Eur Heart J Acute Cardiovasc Care. 2017 6; Jun(4):339–347.
   Google Scholar
• Nwosu AC, Mayland CR, Mason S, et al. Bioelectrical impedance vector analysis (BIVA) as a method to compare body composition differences according to cancer stage and type. Clin Nutr ESPEN. 2019 Apr;30:59–66.
   PubMed Web of Science ®Google Scholar
• Valle R, Aspromonte N, Milani L, et al. Optimizing fluid management in patients with acute decompensated heart failure (ADHF): the emerging role of combined measurement of body hydration status and brain natriuretic peptide (BNP) levels. Heart Fail Rev. 2011 Nov;16(6):519–529.
   PubMed Web of Science ®Google Scholar
• Massari F, Scicchitano P, Iacoviello M, et al. Serum biochemical determinants of peripheral congestion assessed by bioimpedance vector analysis in acute heart failure. Heart Lung. 2019 Sep - Oct;48(5):395–399.
   PubMed Web of Science ®Google Scholar
• UK Biobank. 2019.
   Google Scholar
• Sudlow C, Gallacher J, Allen N, et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015 Mar;12(3):e1001779.
   PubMed Web of Science ®Google Scholar
• Lindholm D, Fukaya E, Leeper NJ, et al. Bioimpedance and new-onset heart failure: a longitudinal study of >500 000 individuals from the general population. J Am Heart Assoc. 2018 Jun 29;7:13.
   Web of Science ®Google Scholar
• Keren H, Burkhoff D, Squara P. Evaluation of a noninvasive continuous cardiac output monitoring system based on thoracic bioreactance. Am J Physiol Heart Circ Physiol. 2007 Jul;293(1):H583–9.
   PubMed Web of Science ®Google Scholar
• Latham HE, Bengtson CD, Satterwhite L, et al. Stroke volume guided resuscitation in severe sepsis and septic shock improves outcomes. J Crit Care. 2017 Dec;42:42–46.
   PubMed Web of Science ®Google Scholar
• Rich JD, Archer SL, Rich S. Noninvasive cardiac output measurements in patients with pulmonary hypertension. Eur Respir J. 2013 Jul;42(1):125–133.
   PubMed Web of Science ®Google Scholar
• Saugel B, Cecconi M, Wagner JY, et al. Noninvasive continuous cardiac output monitoring in perioperative and intensive care medicine. Br J Anaesth. 2015 Apr;114(4):562–575.
   PubMed Web of Science ®Google Scholar
• Rosenblum H, Helmke S, Williams P, et al. Peak cardiac power measured noninvasively with a bioreactance technique is a predictor of adverse outcomes in patients with advanced heart failure. Congest Heart Fail. 2010 Nov-Dec;16(6):254–258.
   PubMedGoogle Scholar
• Engineer RS, Benoit JL, Hicks CW, et al. Hemodynamic changes as a diagnostic tool in acute heart failure–a pilot study. Am J Emerg Med. 2012 Jan;30(1):174–180.
   PubMed Web of Science ®Google Scholar
• Rali AS, Buechler T, Van Gotten B, et al. Non-invasive cardiac output monitoring in cardiogenic shock: the NICOM study. J Card Fail. 2020 Feb;26(2):160–165.
   PubMed Web of Science ®Google Scholar
• Shochat MK, Shotan A, Blondheim DS, et al. Corrigendum to “non-invasive lung impedance-guided preemptive treatment in chronic heart failure patients: a randomized controlled trial (Impedance-HF Trial)”: (Journal of Cardiac Failure (2016) 22(9)(713–722)(S1071916416300082)(10.1016/j.cardfail.2016.03.015)) [Erratum]. J Card Fail. 2016;23(6):512–513.
   Web of Science ®Google Scholar
• Ioannidis JP. Why most published research findings are false. PLoS Med. 2005 Aug;2(8):e124.
   PubMed Web of Science ®Google Scholar
• Gaziano JM. The evolution of population science: advent of the mega cohort. JAMA. 2010 Nov 24;304(20):2288–2289.
   PubMed Web of Science ®Google Scholar
• Sorlie P, Wei GS. Population-based cohort studies: still relevant? J Am Coll Cardiol. 2011 Nov 1;58(19):2010–2013.
   PubMed Web of Science ®Google Scholar
• Sorlie PD, Bild DE, Lauer MS. Cardiovascular epidemiology in a changing world–challenges to investigators and the National Heart, Lung, and Blood Institute. Am J Epidemiol. 2012 Apr 1;175(7):597–601.
   PubMed Web of Science ®Google Scholar